<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pulmonary vascular disease &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pulmonary-vascular-disease/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 11 Oct 2026 07:01:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>pulmonary vascular disease &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>NFAT Transcription Factors Emerge as Central Drivers of Pulmonary Hypertension</title>
		<link>https://bioengineer.org/nfat-transcription-factors-emerge-as-central-drivers-of-pulmonary-hypertension/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 11 Oct 2026 07:01:57 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[calcineurin signaling]]></category>
		<category><![CDATA[Calcium signaling]]></category>
		<category><![CDATA[cyclosporin A]]></category>
		<category><![CDATA[microRNAs]]></category>
		<category><![CDATA[NFAT transcription factors]]></category>
		<category><![CDATA[NFATC3]]></category>
		<category><![CDATA[phenotypic switching]]></category>
		<category><![CDATA[pulmonary artery smooth muscle cells]]></category>
		<category><![CDATA[pulmonary hypertension]]></category>
		<category><![CDATA[pulmonary vascular disease]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[Vascular remodeling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=414165</guid>

					<description><![CDATA[A new review in Molecular Biology Reports synthesizes evidence that NFAT1-4 transcription factors drive the abnormal proliferation of pulmonary artery smooth muscle cells underlying pulmonary hypertension, highlighting therapeutic strategies that target the calcineurin-NFAT axis.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">414165</post-id>	</item>
	</channel>
</rss>
